Vanguard Capital Management
SMTI icon

Vanguard Capital Management’s Sanara MedTech SMTI Stock Holding History

Vanguard Capital Management’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.6M Buy
194,897
+43,530
+29% +$900K ﹤0.01% 3154
2026
Q1 		$2.6M Buy
+151,367
New +$3.11M ﹤0.01% 3272

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management's SMTI Position: Q2 2026 in Review

Vanguard Capital Management increased its Sanara MedTech (SMTI) stake by 29% in Q2 2026, buying an estimated $900K and bringing the position to 194,897 shares worth $4.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3154.

Vanguard Capital Management first reported a position in SMTI in Q1 2026 and has held it in 2 quarters since. 70 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Vanguard Capital Management held 194,897 shares of Sanara MedTech worth $4.6M as of Q2 2026.
  • Vanguard Capital Management bought 43,530 Sanara MedTech shares in Q2 2026, an estimated $900K.
  • Sanara MedTech made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3154 holding.
  • Vanguard Capital Management first reported a position in Sanara MedTech in Q1 2026 and has held it in 2 quarters since.
  • 70 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.